Challenges of Introducing New Biomarker Products for Neuropsychiatric Disorders into the Market-Reference-Cited by-同舟云学术

Challenges of Introducing New Biomarker Products for Neuropsychiatric Disorders into the Market

Published:2011 Issue: Volume: Page:299-327
ISSN:0074-7742
Container-title:International Review of Neurobiology
language:
Short-container-title:

Author:

Bahn Sabine,Noll Richard,Barnes Anthony,Schwarz Emanuel,Guest Paul C.

Publisher

Elsevier

Reference123 articles.

1. Inflammatory and hemostatic response to cardiopulmonary bypass in pediatric population: feasibility of seriological testing of multiple biomarkers;Aĝirbaşli;Artif. Organs,2010

2. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results;Agius;Psychiatr. Danub.,2007

3. Report of the task force on designing clinical trials in early (predementia) AD;Aisen;Neurology,2011

4. Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation;Alymani;Eur. J. Cancer,2010

5. Detecting feigned depression and schizophrenia on the MMPI-2;Bagby;J. Pers. Assess.,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A primer on the use of machine learning to distil knowledge from data in biological psychiatry;Molecular Psychiatry;2024-01-04

2. The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons;Frontiers in Molecular Neuroscience;2021-11-12

3. Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review;Frontiers in Genetics;2021-10-13

4. Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study;Neuropsychiatric Disease and Treatment;2021-08

5. Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond;Human Psychopharmacology: Clinical and Experimental;2020-09-23